- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03893604
Effects of tDCS on High Level and Recreational Athletes
Comparing the Effects of tDCS on Endurance Parameters Between High Level and Recreational Athletes
Healthy recreational and high level athletes will undergo 2 randomized, cross-over counterbalanced sessions of anodal tDCS or sham tDCS.
The primary outcome is an isokinetic evaluation of their hamstrings' and quadriceps' endurance after each session
Study Overview
Detailed Description
Recruitment :
Healthy recreational and high level athletes will be recruited through social media and advertisements.
Each subject came twice to the Liege University Hospitals' isokinetic lab. Each session began with strapping the subjet into the isokinetic machine, making sure that all the settings were adapted to the subject. Then, each subject received either anodal tDCS, of sham tDCS. Neither the evaluator or the subject knew which they were receiving. Immediately following tDCS, there was a warmup consisting of stationary bike, and an isokinetic warmup. Then, subjects' endurance was using a maximal isokinetic tests, at 30 maximal concentric and eccentric contractions at a speed of 180°/s.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Liege, Belgium, 4000
- Liege Univeristy Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- For the "recreational" group at most 3 hours of sport a week
- For the "athletic" group, at least 10 hours of sport a week
- Right handed and footed
Exclusion Criteria:
- One on the TSST (in high and relatively high risk sections)
- Previous neurological or orthopedic pathologies affecting limbs
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Anodal tDCS
Subjects will receive 20min anodal tDCS
|
20 minutes of anodal tDCS (C3/FP2) 2mA or sham
Other Names:
|
|
Sham Comparator: Sham tDCS
Subjects will receive 20 minutes of Sham anodal tDCS
|
20 minutes of anodal tDCS (C3/FP2) 2mA or sham
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak Strength
Time Frame: Immediately after tDCS and sham
|
Peak strength (measured by the isokinetic machine) is measured after each of the 30 repetitions. Peak strength of the 30 repetitions will be measured, and how strength decreases throughout the test will be analysed |
Immediately after tDCS and sham
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stephen Bornheim, Msc, Liege University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2017-313
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.